Arch Biopartners Inc.
ACHFF · OTC
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $111 | $69 | $187 | $106 |
| - Cash | $0 | $1 | $1 | $0 |
| + Debt | $3 | $5 | $4 | $5 |
| Enterprise Value | $114 | $73 | $191 | $110 |
| Revenue | $2 | $2 | $1 | $4 |
| % Growth | 7% | 105.7% | -75.2% | – |
| Gross Profit | -$2 | -$0 | -$1 | -$0 |
| % Margin | -78% | -6.5% | -52.1% | -3.9% |
| EBITDA | $0 | -$3 | -$1 | -$1 |
| % Margin | 0% | -150.2% | -112% | -22.9% |
| Net Income | -$4 | -$3 | -$1 | -$1 |
| % Margin | -184.7% | -167.7% | -146% | -30.1% |
| EPS Diluted | -0.062 | -0.053 | -0.023 | -0.019 |
| % Growth | -15.9% | -134.8% | -18.8% | – |
| Operating Cash Flow | -$2 | -$0 | $0 | -$3 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$0 | $0 | -$3 |